Sep 29, 2020 11:00 am EDT bioAffinity Technologies Announces Dr. Martin Tammemägi to Chair Scientific and Medical Advisory Board
Aug 12, 2020 10:00 am EDT Precision Pathology Services and bioAffinity Technologies Announce Initiation of CLIA Validation for Non-Invasive Early Lung Cancer Test
Aug 4, 2020 10:00 am EDT bioAffinity Technologies Announces Poster Presentation at CYTO 2020 Conference
Jul 28, 2020 10:00 am EDT bioAffinity Technologies Announces Closing of $5,000,000 Convertible Note Financing
Jun 16, 2020 9:00 am EDT bioAffinity Cancer Research Laboratories Named for Philanthropist Harvey Sandler
Jun 10, 2020 2:33 pm EDT bioAffinity Technologies Validation Trial for Non-Invasive Lung Cancer Test Results in High Sensitivity and Specificity
Oct 2, 2019 11:00 am EDT bioAffinity Technologies Announces Members of its Scientific and Medical Advisory Board
